V004-4314 Screening compound: N-{4-[4-(2-methoxyphenyl)piperazin-1-yl]-3-[(1-phenylethyl)sulfamoyl]phenyl}cyclobutanecarboxamide

V004-4314 Screening compound: N-{4-[4-(2-methoxyphenyl)piperazin-1-yl]-3-[(1-phenylethyl)sulfamoyl]phenyl}cyclobutanecarboxamide
V004-4314 Screening compound: N-{4-[4-(2-methoxyphenyl)piperazin-1-yl]-3-[(1-phenylethyl)sulfamoyl]phenyl}cyclobutanecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V004-4314
N-{4-[4-(2-methoxyphenyl)piperazin-1-yl]-3-[(1-phenylethyl)sulfamoyl]phenyl}cyclobutanecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V004-4314

Molecular Formula

C30H36N4O4S (C30 H36 N4 O4 S)

Compound Name

N-{4-[4-(2-methoxyphenyl)piperazin-1-yl]-3-[(1-phenylethyl)sulfamoyl]phenyl}cyclobutanecarboxamide

IUPAC name

N-{4-[4-(2-methoxyphenyl)piperazin-1-yl]-3-[(1-phenylethyl)sulfamoyl]phenyl}cyclobutanecarboxamide

SMILES

CC(c1ccccc1)NS(c(cc(cc1)NC(C2CCC2)=O)c1N(CC1)CCN1c(cccc1)c1OC)(=O)=O

InChI

InChI=1S/C30H36N4O4S/c1-22(23-9-4-3-5-10-23)32-39(36,37)29-21-25(31-30(35)24-11-8-12-24)15-16-27(29)34-19-17-33(18-20-34)26-13-6-7-14-28(26)38-2/h3-7,9-10,13-16,21-22,24,32H,8,11-12,17-20H2,1-2H3,(H,31,35)/t22-/m0/s1

InChI Key

RVOFHLDBVVXPES-QFIPXVFZSA-N

MDL Number (MFCD)

MFCD19972643

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

548.71

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.437

Distribution Coefficient, logD

4.435

Water Solubility, LogSw

-4.16

Polar Surface Area

78.729

Acid Dissociation Constant (pKa)

9.89

Base Dissociation Constant (pKb)

3.31

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

36.70

V004-4314 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V004-4314 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V004-4314?
Check Price and Availability of V004-4314, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V004-4314 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V004-4314
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V004-4314
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V004-4314 available by request